Granzyme B PET Imaging Stratifies Immune Checkpoint Inhibitor Response in Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is a notoriously difficult cancer to treat. The recent development of immune checkpoint inhibitors has revolutionised HCC therapy; however, successful response is only observed in a small percentage of patients. Biomarkers typically used to predict treatment response i...
Saved in:
| Main Authors: | Julian L. Goggi, Boominathan Ramasamy, Yun Xuan Tan, Siddesh V. Hartimath, Jun Rong Tang, Peter Cheng, Rasha Msallam, Ann-Marie Chacko, You Yi Hwang, Edward G. Robins |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2021-01-01
|
| Series: | Molecular Imaging |
| Online Access: | http://dx.doi.org/10.1155/2021/9305277 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Facile Automated Radiosynthesis of an Arginine Selective Bioconjugation Reagent 4‑[18F]Fluorophenylglyoxal for Developing Protein-Based PET Molecular Probes
by: Pragalath Sadasivam, et al.
Published: (2025-05-01) -
Oxygen-delivery nanoparticles enhanced immunotherapy efficacy monitored by granzyme B PET imaging in malignant tumors
by: Xingyi Wang, et al.
Published: (2025-03-01) -
Editorial: Roles of granzymes in inflammation, aging, and autoimmunity
by: Fehim Esen, et al.
Published: (2025-08-01) -
Pro-inflammatory granzyme K contributes extracellularly to disease
by: Christopher T. Turner
Published: (2025-06-01) -
Granzyme B May Act as an Effector Molecule to Control the Inflammatory Process in COPD
by: Won-Dong Kim, et al.
Published: (2024-12-01)